Greater Than One (GTO) has been recognized by PM360 for its success in conceiving and launching a virtual campaign to support OXLUMO® (lumasiran), a first-in-class therapy developed by Alnylam.
Chief Executive Officer and Honeycomb Health (HH) co-founder Elizabeth Apelles discusses why the high-tech nonprofit will forever change the lives of rare disease patients everywhere, and shares the buzz about her co-founder’s road trip to raise $3M dollars.
Signaling the end of an era in digital communications, all major browsers will cease supporting third-party cookies by the end of 2021. GTO’s Engagement Strategist details the impact of that change and shares some tools marketers can use to drive success in the cookieless future.
Chris Mycek comes to Greater Than One (GTO) with experience launching first-in-class therapies and an impassioned commitment to the company’s vision. He plans to make client businesses better by leveraging new technologies, emerging marketing channels, and the fully integrated GTO Group model.